http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008203024-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f7da3160653b97db1bf0bcf554f5b0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85781acc6296f888fa3796c29b75be7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a77e5263f98f3f737a65ec011e57ae5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b9c3763e2d616c90725dae9e31c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39d834128384ecf1d633c57b598f3aa2
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0439
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3633
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D61-00
filingDate 2006-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0bd43a031da1d438949730b1d3a2858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f33e2a374c3cb76b3a417cd87ed2389b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0f03fa16cddd0600a20e83342bd9b0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_557642b8349b5bf1d0a5c2030bba1110
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a83725a4827fb96289456b620fc584f0
publicationDate 2008-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2008203024-A1
titleOfInvention Method for the Elimination of Leukocytes from Blood
abstract The invention relates to a method for reducing the number of leukocytes in blood through treating the blood in an arrangement of a plurality of fibers based on organic polymers, whereby the blood is channeled along the fibers and whereby the reduction in leukocytes from the blood occurs essentially through adsorption on the fibers, characterized in that the plurality of fibers based on organic polymers is fixed in a housing with an inlet arrangement and an outlet arrangement, and that the blood is channeled via the inlet arrangement into the housing, flows through the housing with the plurality of fibers made from organic polymers, and exits the housing via the outlet arrangement, that the arrangement of the fibers shows a high degree of order, that the blood flows along the external surface of the fibers, and that the fibers cause a generation of the complement activation product C5 a in a concentration of at least 10 μg per m 2 of fiber surface.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8541538-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8251941-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016030357-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011196280-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010266562-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010266563-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010268146-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010268147-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8425445-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8425446-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8425447-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9128093-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012258011-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10722637-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8430832-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11118162-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8748560-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11439739-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8409126-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009060890-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9341626-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010084331-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10695482-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9498566-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7985337-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011033704-A1
priorityDate 2005-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6498007-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6193896-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4497104-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6375876-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4925572-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4882106-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5407581-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6045701-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4882223-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128671575
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471

Total number of triples: 64.